CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease Haemodynamic definitions and updated clinical classification of pulmonary hypertension Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature Circulating Plasma microRNAs In Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Update on chronic thromboembolic pulmonary hypertension Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial

Original ResearchNov 2015

JOURNAL:CIRC-CARDIOVASC INTE. Article Link

Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes

SL Chen, H Zhang, GW Stone et al. Keywords: PADN

Full Text PDF